#AIEye
#Podcast 693: #Stocks discussed: (OTCPINK: $GTCH) (NYSE: $ZBH) #artificialintelligence
GBT
to Further Broaden Innovative IC Design, and Zimmer Biomet Adds New AI
Capabilities to Omni Suite
Global
#AI in #Pharma Market to Reach $3.62B by 2026
Vancouver, Kelowna, Delta, BC – May 11, 2022 – Investorideas.com,
a global investor news source covering Artificial Intelligence (AI) brings
you today’s edition of The
AI Eye-watching stock news, deal tracker and advancements in
artificial intelligence – featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).
Listen
to today’s podcast:
https://www.investorideas.com/Audio/Podcasts/2022/051122-AI-Eye.mp3
Read
this in full at https://www.investorideas.com/news/2022/artificial-intelligence/05111GTCH-ZBH.asp
Today’s
Column- The
AI Eye- Watching stock news, deal tracker and advancements
in artificial intelligence
Stocks
discussed: (OTCPINK:GTCH) (NYSE:ZBH)
GBT Technologies Inc. (OTC PINK:GTCH) has announced that it will be further broadening
its 3D, multiplanar, integrated circuits design and manufacturing continuation
patent application. The press release indicates that the invention could be a
significant development, “particularly for integrated circuits that require
vast amounts of silicon space like memories, CPU, GPU and AI.” The company’s
CTO, Danny Rittman, explained:
“We
believe this is an innovative concept, designed to be accompanied with scaling
down ICs size to fit into smaller electronic devices. Redesigning and
manufacturing microchips with multiplanetary architecture would enable placing
more circuitries on same or smaller space silicon dies, which would expect to
significantly lower their cost. The 3D microchip continuation application is
planned to broaden the original patent with design and fabrication concepts.
With the ever-growing microchip's complexity, demand for less power, faster
performance and smaller size, we believe that the presented patent's technology
can be an efficient solution, enabling economical IC's design and
manufacturing, creating new horizons and standards.”
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has introduced new artificial intelligence (AI)
capabilities within the Omni Suite, described in the press release as “an
intelligent operating room (OR) designed to optimize surgical workflow and
procedural efficiency.” The new AI feature “uses cameras to automatically
recognize and timestamp key OR workflow milestones,” and “further expands the
AI capabilities of ZBEdge, a suite of integrated smart, digital and robotic
technologies designed to deliver transformative data-powered clinical insights
with the goal of improving patient outcomes.” Zimmer Biomet’s COO, Ivan Tornos,
said:
"Omni
Suite's latest feature further enhances the value and utility of the Omni Suite
platform while adding AI capabilities to strengthen our ZBEdge Connected
Intelligence Suite. Omni Suite, along with the smart, digital and robotic
solutions that make up ZBEdge, allow us to create value innovation that unlocks
data-driven insights to enhance the surgical experience for surgeons, care
teams and patients."
Global
AI in Pharma Market to Reach $3.62B by 2026
A report published by Research and Markets finds that the global
market for AI in Pharma is projected to grow from $1.23 billion USD in 2022 to
$3.62 billion in 2026, registering a compound annual growth rate (CAGR) of 30.9
percent in the forecast period. The following excerpt from the report’s summary
outlines the role of AI in clinical trials as a key market driver:
The
growing adoption of artificial intelligence (AI) for clinical trials research
is driving its demand for AI in the pharmaceutical market. To bring a new drug
to the market takes on average 10–15 years approximately and half of this time
is consumed during the clinical trial phases of the drug development cycle.
Hence, using AI models and analytics tools can accelerate the clinical trial
phases, perception of diseases, identify suitable cases and key investigators
to inform site selection, and support novel clinical study designs.
Sam Mowers, Investorideas.com
Read and
hear other editions of the AI Eye
For a list of
artificial intelligence stocks on Investorideas.com visit
here
About
GBT Technologies Inc.
GBT
Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which
considers itself a native of Internet of Things (IoT), Artificial Intelligence
(AI) and Enabled Mobile Technology Platforms used to increase IC performance.
GBT has assembled a team with extensive technology expertise and is building an
intellectual property portfolio consisting of many patents. GBT’s mission, to
license the technology and IP to synergetic partners in the areas of hardware
and software. Once commercialized, it is GBT’s goal to have a suite of products
including smart microchips, AI, encryption, Blockchain, IC design, mobile
security applications, database management protocols, with tracking and
supporting cloud software (without the need for GPS). GBT envisions this system
as a creation of a global mesh network using advanced nodes and super
performing new generation IC technology. The core of the system will be its
advanced microchip technology; technology that can be installed in any mobile
or fixed device worldwide. GBT’s vision is to produce this system as a low
cost, secure, private-mesh-network between any and all enabled devices. Thus,
providing shared processing, advanced mobile database management and sharing
while using these enhanced mobile features as an alternative to traditional
carrier services.
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
publishes breaking stock news, third party stock research, guest posts and
original articles and podcasts in leading stock sectors. Learn about investing in stocks and get
investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy, gaming and more. Investor Idea’s original branded content
includes podcasts and columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and
the AI
Eye Podcast.
The
Investorideas.com podcasts are also available on Apple Podcasts , Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio, Google Podcasts
and most audio platforms available.
Visit the Podcast
page at Investorideas.com: https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions.
Disclosure: GTCH is a paid
featured AI stock More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about
publishing your news release and our other news services on the Investorideas.com
newswire https://www.investorideas.com/News-Upload/ Global investors must
adhere to regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye-
Watching stock news, deal tracker and advancements in artificial
intelligence is an original content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact
Investorideas.com
800 665 0411
Get more Technology stock investor
ideas - news, articles, podcasts and stock directories
No comments:
Post a Comment